Lack of Cannabinoid Type 2 Promoter Activity in Normal or Injured Kidneys Using a Cnr2-GFP Reporter Mouse.

Area of Science:

• Nephrology
• Pharmacology
• Immunology

Background:

• Cannabinoid type 2 (CB2) receptor activity influences kidney function.
• Existing data on CB2 receptor protein levels and distribution in the kidney is inconsistent.
• Understanding CB2 receptor expression is crucial for therapeutic targeting in kidney disease.

Purpose of the Study:

• To investigate CB2 receptor expression and localization in mouse kidneys under various injury conditions.
• To utilize a genetic mouse model expressing green fluorescent protein (GFP) under the Cnr2 promoter to track CB2 levels.

Main Methods:

• Kidney injury induced by cisplatin, lipopolysaccharide (LPS), or unilateral ureteral obstruction (UUO) in Cnr2-GFP reporter mice.
• Quantification of GFP as a proxy for CB2 levels via Western blot and RT-PCR for Cnr2 mRNA.
• Localization of GFP fluorescence using fluorescent microscopy in kidney sections.

Main Results:

• Minimal to undetectable GFP protein and Cnr2 mRNA levels were observed in control and injured kidneys.
• GFP fluorescence was absent in intrinsic kidney cells (tubules, glomeruli, vasculature) but detected in rare interstitial cells.
• Similar low expression patterns were consistent across chemical and obstructive kidney injury models.

Conclusions:

• The Cnr2 promoter shows minimal activity in normal and injured kidney intrinsic cells.
• CB2 receptor expression in the injured kidney may primarily involve recruited cells rather than resident kidney cells.
• Pharmacological targeting of CB2 receptors in kidney injury warrants careful consideration of cell-specific expression.